Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial

By  

Cardiology, Vol. 136, Iss. 2, 2016-09 ,pp. : 128-137

Karger

Access to resources Recommend Favorite

Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI‐HF and Val‐HeFT trials

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 4, 2015-04 ,pp. : 424-433

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the High‐Risk Myocardial Infarction Database Initiative

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1144-1151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of Intravenous Levosimendan in Patients with Heart Failure Complicated by Acute Myocardial Infarction

By  

Cardiology, Vol. 128, Iss. 2, 2014-04 ,pp. : 195-201

Karger

Access to resources Recommend Favorite

Rationale and design of a randomized, double‐blind, event‐driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: the COMMANDER HF trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 7, 2015-07 ,pp. : 735-742

John Wiley & Sons Inc

Access to resources Recommend Favorite